Iridium Q2 Earnings Miss Estimates Despite Revenue Growth; Aireon Acquisition Remains Key Catalyst

What happened

Iridium reported Q2 2026 earnings that missed consensus EPS estimates, though revenue exceeded forecasts driven by new satellite products and growth in commercial services. The company's strategic focus remains on the pending Aireon acquisition and the Rocket Lab partnership, which are expected to reshape its growth profile. However, the EPS miss underscores near-term margin pressure and higher operating expenses amid the investment cycle. The market reacted cautiously as investors weigh the potential long-term benefits of these deals against the current financial stretch. Overall, Iridium's execution on its transformation plan will be critical to justify the premium valuation.

Implication

The Q2 EPS miss, while offset by revenue growth, highlights that Iridium's transformation is still in the investment phase with rising leverage. The stock's rally prices in successful execution of Aireon integration and NTN Direct commercial launch. Without confirmed milestones—Aireon closing and tracking to $100M+ revenue and $30M+ OEBITDA, and EMSS renewal clarity—the risk/reward is unfavorable. The DeepValue report maintains a WAIT rating with attractive entry at $42 and trim above $56. Investors should not chase the current price near $51; instead, wait for Q3 2026 disclosures to confirm the thesis.

Thesis delta

The Q2 earnings miss does not alter the fundamental thesis but reinforces the wait stance by highlighting near-term cost pressures. The key catalysts—Aireon close and EMSS renewal—remain unchanged and still require hard proof points in coming months. The stock's elevated valuation leaves little room for error, so the risk/reward remains asymmetrically negative until execution is confirmed.